Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A "deficient endogenous enzyme" describes any situation where an individual has insufficient activity or quantity of an essential naturally occurring human enzyme. This state is most frequently caused by inherited genetic mutations leading to loss-of-function alleles. The result is disruption in specific metabolic pathways—either through toxic build-up upstream from the block or lack of critical downstream products—which manifests as various clinical syndromes depending on the affected pathway. Examples include phenylketonuria (phenylalanine hydroxylase deficiency), Tay–Sachs disease (hexosaminidase A deficiency), mucopolysaccharidoses such as Hurler syndrome, and DNA repair disorders like xeroderma pigmentosum. Diagnosis relies on biochemical assays and genetic testing; treatment options depend on the specific disorder but may involve dietary management, replacement therapy with exogenous enzymes, or supportive care[1][2][3].
Varies depending on the specific deficient enzyme and therapeutic approach. Dietary management aims to reduce substrate accumulation. Enzyme replacement therapy provides exogenous enzyme to compensate for the deficiency. Substrate reduction therapy decreases the production of the substrate of the deficient enzyme. Chaperone therapy stabilizes misfolded enzymes.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deficient Endogenous Enzyme.